309. Progressive myoclonus epilepsy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 11 / Drugs : 15 - (DrugBank : 2) / Drug target genes : 4 - Drug target pathways : 9
Progressive myoclonus epilepsy and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
309 | Progressive myoclonus epilepsy |
6 | Parkinson disease |
2 | Amyotrophic lateral sclerosis |
4 | Primary lateral sclerosis |
7 | Corticobasal degeneration |
74 | Prolactin secreting pituitary adenoma |
20 | Adrenoleukodystrophy |
201 | Angelman syndrome |
164 | Oculocutaneous albinism |
140 | Dorabe syndrome |
90 | Retinitis pigmentosa |
17 | Multiple system atrophy |
8 | Huntington disease |
299 | Cystic fibrosis |
86 | Pulmonary arterial hypertension |
206 | Fragile X syndrome |
13 | Multiple sclerosis/Neuromyelitis optica |